Neurology 912 - Neurology Alert - Dec 01, 2005

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Fred Plum, MD
University Professor;
Department of Neurology;
Cornell University Medical College

Assistant Editors
Matthew Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Chief
Division of Stroke and Critical Care Neurology
New York Presbyterian Hospital

Michael Rubin, MD
Professor of Clinical Neurology
New York Presbyterian Hospital-Cornell Campus

Alan Z. Segal, MD
Assistant Professor
Department of Neurology
Weill-Cornell Medical College
Attending Neurologist
New York Presbyterian Hospital

Authors
Dana Leifer, MD
Associate Professor
Neurology
Weill Medical College of Cornell University

Dara G. Jamieson, MD
Associate Professor
Clinical Neurology
Weill Medical College of Cornell University

Associate Editor
John J. Caronna, MD
Vice-Chairman
Department of Neurology
Cornell University Medical Center;
Professor of Clinical Neurology
New York Hospital

Subjects:

  • Is Snoring a Risk Factor for Stroke?
  • Hyperglycemia Associated with Decreased Recanalization After IV t-PA in Acute Stroke
  • HTLV-1 and the Peripheral Nervous System
  • Strokes Too Mild for IV tPA May Still Have Severe Outcomes
  • Clopidogrel and Aspirin: New Data From COMMIT
  • Pathophysiology of Muscle Cramps
  • Topiramate for Migraine

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present "basic science? lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Fred Plum, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Assistant editor Matthew Fink, MD, author Dana Leifer, MD, associate editor John J. Caronna, MD, and author Dara G. Jamieson, MD report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study. Assistant editor Michael Rubin, MD is on the speaker’s bureau for Athena Diagnostics, and does research for Pfizer and Merck. Assistant editor Alan Z. Segal, MD is on the speaker's bureau of Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.